Pre-clinical development of viral vectored transmission-blocking malaria vaccines by Kapulu, MC

Controlled Human Malaria Infection in Semi-Immune Kenyan Adults (CHMI-SIKA): A study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of... by Kapulu, MC, Njuguna, P, Hamaluba, MM, Chmi-Sika Study Team

Immune responses to gametocyte antigens in a malaria endemic population—the African falciparum context: a systematic review and meta-analysis by Muthui, MK, Kamau, A, Bousema, T, Blagborough, AM, Bejon, P, Kapulu, MC

Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response by Kapulu, MC, Kimani, D, Njuguna, P, Hamaluba, M, Otieno, E, Kimathi, R, Tuju, J, Sim, BKL

Assessment of antibodies induced by multivalent transmissions-blocking malaria vaccines by Menon, V, Kapulu, MC, Taylor, I, Jewell, K, Li, Y, Hill, F, Long, CA, Miura, K, Biswas, S

Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection by Kapulu, MC, Njuguna, P, Hamaluba, M, Kimani, D, Ngoi, JM, Musembi, J, Ngoto, O, Otieno, E, Billingsley, PF

The Dantu blood group prevents parasite growth in vivo: evidence from a controlled human malaria infection study by Kariuki, SN, Macharia, AW, Makale, J, Nyamu, W, Hoffman, SL, Kapulu, MC, Bejon, P, Rayner, JC, Williams, TN

Breadth of antibodies to Plasmodium falciparum variant surface antigens is associated with immunity in a controlled human malaria infection study by Kimingi, HW, Kinyua, AW, Achieng, NA, Wambui, KM, Mwangi, S, Nguti, R, Kivisi, CA, Jensen, ATR, Bejon, P, Kapulu, MC, Abdi, AI, Kinyanjui, SM

Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria by Musasia, FK, Nkumama, IN, Frank, R, Kipkemboi, V, Schneider, M, Mwai, K, Odera, DO, Rosenkranz, M, Fürle, K, Kimani, D, Tuju, J, Njuguna, P, Hamaluba, M, Kapulu, MC, Wardemann, H, Osier, FHA

Undertaking community engagement for a controlled human malaria infection study in Kenya: approaches and lessons learnt by Mumba, N, Njuguna, P, Chi, P, Marsh, V, Awuor, E, Hamaluba, M, Mauncho, C, Mwalukore, S, Masha, J, Mwangoma, M, Kalama, B, Alphan, H, Wambua, J, Bejon, P, Kamuya, D, Kapulu, MC

Comparing drug regimens for clearance of malaria parasites in asymptomatic adults using PCR in Kilifi County, Kenya: an open-label randomised controlled clinical trial (MalPaC) by Khaemba, EN, Ogwang, C, Kinyanjui, S, Muindi, JM, Koske, JK, Kimani, D, Ngoi, J, Mwacharo, J, Shangala, J, Njuguna, P, Mutinda, D, Nyatichi, E, Peshu, J, Mutinda, B, Ndungu, FM, Farnert, A, Bashraheil, MM, Bejon, P, Kapulu, MC

Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity. by Gonçalves, BP, Kapulu, MC, Sawa, P, Guelbéogo, WM, Tiono, AB, Grignard, L, Stone, W, Hellewell, J, Lanke, K, Bastiaens, GJH, Bradley, J, Nébié, I, Ngoi, JM, Oriango, R, Mkabili, D, Nyaurah, M, Midega, J, Wirth, DF, Marsh, K, Churcher, TS, Bejon, P, Sirima, SB, Drakeley, C, Bousema, T